Cooper Companies

Traded on the St. Petersburg Stock Exchange
The Cooper Companies, Inc. is a global medical device company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI) which manufactures medical devices and fertility and genomic products for the women’s health care market.
Cooper Companies stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
Debts
Net debt
Yield
Growth potential

Cooper Companies balance sheet

Report period2019 2020 2021 2022 2023 Q3 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Cooper Companies cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Cooper Companies multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Cooper Companies profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Cooper Companies assets
Cooper Companies cash flows
Cooper Companies dividends
0%

Cooper Companies shares

TickerNameTypeNominal valueISINPrice
COO:USCooper Companies Inc.Common share-US2166484020$100.4
Cooper Companies news
14.12.2022
The Cooper Companies Board of Directors announced a quarterly dividend of $0.03 per share. The last day to buy securities to receive the dividend is January 19, 2023. The annual dividend yield may reach 0.02%.
14.07.2022
The Cooper Companies Board of Directors announced a quarterly dividend of $0.03 per share. The last day to buy securities to receive the dividend is July 25, 2022. The annual dividend yield may reach 0.02%.
03.06.2022
Cooper Companies' GAAP net income for 6 months of fiscal year 2022 was $0.222 billion, down 10 times from $2.219 billion in the previous year. Revenues increased 15.5% to $1.617 billion from $1.4 billion a year earlier.
04.03.2022
Cooper Companies' GAAP net income for 3 months of fiscal year 2022 was $0.095 billion, down 22.1 times from $2.101 billion in the prior year. Revenue increased 15.7% to $787.2 billion from $680.5 billion a year earlier.
General information
Company nameCooper Companies
Tags#s&p500 index
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business address6140 STONERIDGE MALL RD STE 590 PLEASANTON CA 94588 9254603600
Mailing address6140 STONERIDGE MALL ROAD SUITE 590 PLEASANTON CA 94588
Websitewww.coopercos.com
Information disclosurewww.sec.gov